Ensemble Therapeutics is a startup based in the United States, most recent round Acquired.
Ensemble Therapeutics is a startup based in the United States. Ensemble Therapeutics has been acquired.
Ensemble Therapeutics was a biopharmaceutical company founded in 2003 that developed a novel class of therapeutics called Ensemblins™, designed to target drug sites considered inaccessible by conventional small molecules. The company ceased operations in 2017.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.